2020
DOI: 10.30906/0869-2092-2020-83-4-31-36
|View full text |Cite
|
Sign up to set email alerts
|

Антидепрессивная Активность И Потенциальные Механизмы Действия Производного Диазепинобензимидазола Даб-19

Abstract: Изучена антидепрессивная активность 11-[4-трет-бутилбензил]-2,3,4,5-тетрагидро[1,3]диазепино[1,2-a]-бензимидазола гидробромида (ДАБ-19), и его возможных взаимодействий с ГАМК-рецепторами и основными катехоламинами ЦНС, а также моноаминоксидазной активности. По результатам проведенного исследования показано, что ДАБ-19 в дозе 2,34 мг/кг обладает умеренной антидепрессивной активностью на модели «Принудительное плавание по Porsolt», (78,0 ± 7,30) с для ДАБ-19 и (98,32 ± 11,54) с для группы контроля, и «Подвешиван… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
1
0
1

Year Published

2020
2020
2022
2022

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 7 publications
1
1
0
1
Order By: Relevance
“…It can indicate either pronounced emotionality in the animals, which is not confirmed by the number of boluses as one of the observed parameters, or a positive effect on the cognitive aspect of the experimental rodents` behavior, which is supported by a distinct anxiolytic effect of DAB-19 in previous study (Spasov et al 2018).The suppression of natural fear of open spaces allows animals to show interest in exploring new territories. The anxiolytic effect of DAB-19 is also confirmed by a high number of entries to the central lit area, rarely recorded short-term self-groomings (which is known to indicate the nervous state of the animal) and a large number of acts of prolonged groomings (which is consistent with the results of screening and in-depth studies of the anti-anxiety activity of the compound) (Spasov et al 2018;Spasov et al 2020).…”
Section: Resultssupporting
confidence: 66%
“…It can indicate either pronounced emotionality in the animals, which is not confirmed by the number of boluses as one of the observed parameters, or a positive effect on the cognitive aspect of the experimental rodents` behavior, which is supported by a distinct anxiolytic effect of DAB-19 in previous study (Spasov et al 2018).The suppression of natural fear of open spaces allows animals to show interest in exploring new territories. The anxiolytic effect of DAB-19 is also confirmed by a high number of entries to the central lit area, rarely recorded short-term self-groomings (which is known to indicate the nervous state of the animal) and a large number of acts of prolonged groomings (which is consistent with the results of screening and in-depth studies of the anti-anxiety activity of the compound) (Spasov et al 2018;Spasov et al 2020).…”
Section: Resultssupporting
confidence: 66%
“…In previous studies, the products of the combination of a diazepine scaffold with benzimidazole moiety were studied -2,3,4,5-tetrahydro[1,3]diazepino[1,2-a]benzimidazole hydrochlorides under the general code DAB (Spasov et al 2018). For various representatives of this series of compounds, a wide range of neurotropic effects have been noted -anxiolytic, antidepressant, anticonvulsant, hypnotic, and some others (Miroshnikov et al 2020, Spasov et al 2020a; however, no adverse drug reactions of the benzodiazepine group were noted for them. Further search for effective anxiolytics among the combinations of the benzodiazepine core structure with the hit structures of various chemical classes seems promising: in the present study, the products of the combina-tion of 1,2,4-triazole and 2,3-benzodiazepine, derivatives of 6-(4-methoxyphenyl)-7H-[1,2,4]triazolo [3,4-A][2,3] benzodiazepine under the general laboratory code RD were investigated.…”
Section: Introductionmentioning
confidence: 99%
“…Назначаемые антидепрессанты и транквилизаторы имеют ряд недостатков: возможен длительный латентный период формирования терапевтического эффекта, а также его недостаточная широта и стойкость, риск токсических эффектов при передозировке, высокая вероятность развития побочных эффектов, что часто становится причиной отказа от назначаемой терапии [3]. Эти факторы делают актуальными поиск и разработку психотропных препаратов, обладающих поливалентным действием, сочетающих собственно антидепрессивную активность со способностью устранять тревожную симптоматику, положительно влиять на интеллектуально-мнестические функции пациента, с быстрым развитием психотропного эффекта и достаточной терапевтической широтой [4].…”
unclassified